GTCM
HLVX

Gyon Technologies Capital Management’s HilleVax HLVX Stock Holding History

Gyon Technologies Capital Management’s Portfolio HLVX Stock Details HLVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,144
Closed -$52.6K – 183
2022
Q4 		$52.6K Buy
+3,144
New +$56.8K 0.02% 397

Other funds holding HLVX

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Gyon Technologies Capital Management's HLVX Position: Q1 2023 in Review

Gyon Technologies Capital Management sold out of HilleVax (HLVX) in Q1 2023, closing a stake of 3,144 shares — an estimated $52.6K sold.

Gyon Technologies Capital Management first reported a position in HLVX in Q4 2022 and held it in 1 quarter. The position peaked at $52.6K in Q4 2022. 61 funds tracked by Wall St. Rank hold HLVX as of Q1 2023.

  • Gyon Technologies Capital Management reported no remaining HilleVax position as of Q1 2023 after selling out during the quarter.
  • Gyon Technologies Capital Management sold 3,144 HilleVax shares in Q1 2023, an estimated $52.6K.
  • Gyon Technologies Capital Management first reported a position in HilleVax in Q4 2022 and held it in 1 quarter.
  • Gyon Technologies Capital Management's HilleVax position peaked at $52.6K in Q4 2022.
  • 61 funds tracked by Wall St. Rank held HilleVax as of Q1 2023.

Based on Gyon Technologies Capital Management's 13F filing for Q1 2023.